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Abstract
Background: Glucagon-like peptide-1 and its receptor agonist-exendin-4 (Ex-4) have been
shown to provide beneficial effects for cardiovascular diseases. This study investigated the
effects of Ex-4 on ischemia-induced ventricular arrhythmias in rats.
Methods: Anesthetized male rats were once treated with Ex-4 (5 µg/kg, i.v.) 1 h before ischemia
in the absence and/or presence of 5-hydroxydecanoic acid (5-HD, 10 mg/kg, i.v., a specific
inhibitor of mitochondrial ATP-sensitive potassium [KATP] channels) which were once
injected 10 min before ischemia. And then subjected to ischemia for 30 min. Ventricular
arrhythmias were assessed.
Results: During the 30-min ischemia, Ex-4 significantly reduced the incidence of ventricular
fibrillation (VF) (p < 0.05). The duration of ventricular tachycardia (VT) + VF, the number
of VT + VF episodes and the severity of arrhythmias were all significantly reduced by Ex-4
compared to those in myocardial ischemia group (p < 0.05 for all). Administration of 5-HD
abolished the protective effects of Ex-4 on VF incidence, the duration of VT + VF, the number
of VT + VF episodes and the severity of arrhythmias (p < 0.05 for all).
Conclusions: This study suggested that Ex-4 could attenuate ischemia-induced ventricular
arrhythmias in rats in which mitochondrial KATP channels may be involved. (Cardiol J 2013;
20, 1: 29–33)
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Introduction
Glucagon-like peptide-1 (GLP-1), a gut incre-
tin hormone secreted from L cells in the intestine
in response to food intake, has currently been con-
sidered as an attractive agent for the management
of type-2 diabetes mellitus (T2DM) [1], and the
GLP-1 receptor agonist-exendin-4 (Ex-4), which is
a 39 amino acid peptide, activates GLP-1 receptors
to increase intracellular cAMP in pancreatic acinar
cells and has no effect on VIP receptors and func-
tion as well as GLP-1. So far, there is emerging
evidence that GLP-1 and Ex-4 could provide bene-
ficial effects for cardiovascular diseases in both ex-
perimental models and patients [2–5]. Recently,
Chinda et al. [6] showed that dipeptidyl peptidase-4
inhibitor, a drug for postponing the degradation of
GLP-1, could provide an anti-arrhythmic effect during
myocardial ischemia (MI), indicating that GLP-1 or
GLP-1 receptor agonist may provide an anti-ar-
rhythmic effect during MI.
Mitochondrial ATP-sensitive potassium (KATP)
channels have been shown to be a mediator or trig-
ger of ischemic preconditioning or pharmacological
preconditioning during MI-reperfusion injury [7–9].
Recently, mitochondrial KATP channels was shown to
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be involved in the anti-arrhythmic effects of ischemic
preconditioning and pharmacological preconditioning
during acute MI [10–12]. Thus, we hypothesized that
GLP-1 receptor agonist-Ex-4 may provide an anti-
arrhythmic effect via mitochondrial KATP channels.
This hypothesis was tested in a rat MI model in
the present study.
Methods
Animal preparation and experimental designs
The experimental protocol conformed to the
Guideline for the Care and Use of Laboratory Ani-
mals published by the US National Institutes of
Health (NIH Publication, revised 1996) and was
approved by Institutional Animal Care and Use
Committee. A total of 40 male Sprague Dawley rats
(250–300 g) were randomly assigned into 4 groups
receiving the following treatments: Group 1 — MI
(n = 10): the rats were subjected to left anterior
descending coronary artery occlusion for 30 min,
1 h before coronary artery occlusion, the rats were
once treated with sterile saline; Group 2 — MI +
+ Ex-4 (MI + Ex-4) (n = 10): the rats were once
treated with Ex-4 (5 µg/kg, i.v., Sigma, USA) [13] 1 h
before left anterior descending coronary artery oc-
clusion. The Ex-4 was dissolved in sterile saline;
Group 3 — MI + Ex-4 + 5-hydroxydecanoic acid
(MI-Ex-4-5-HD) (n = 10): after rats were treated
with Ex-4, 5-HD (a specific of mitochondrial KATP
channels inhibitor, 10 mg/kg, i.v., Sigma, USA) [11]
was once injected 10 min before left anterior de-
scending coronary artery occlusion. The 5-HD was
dissolved in sterile saline; Group 4 — MI + 5-HD
(MI-5-HD) (n = 10): 5-HD (10 mg/kg, i.v.) was once
injected 10 min before left anterior descending co-
ronary artery occlusion.
After being anesthetized with sodium pento-
barbital (45 mg/kg, i.p.), the rats were ventilated
artificially with a volume-controlled rodent respi-
rator at 70 strokes per minute. All rats were placed
on an electric heating pad to maintain their body
temperature at 37°C. Heparin (200 IU/kg, i.v.) was
given before ischemia. The right common carotid
artery and left jugular vein were cannulated to mea-
sure mean arterial blood pressure (MBP) and ad-
ministrate saline or drugs, respectively. Lead II of
the electrocardiogram was monitored with subcu-
taneous stainless steel electrodes. A computer-
based EP system (LEAD2000B, Jinjiang Ltd, Chi-
na) was used for recording MBP, heart rate and
electrocardiogram.
A thoracotomy through a left parasternal inci-
sion was performed. The pericardium was incised,
and the anterior wall of the left ventricle was ex-
posed. A 4-0 silk suture on a small curved needle
was passed through the myocardium beneath the
middle segment of the left anterior descending co-
ronary artery occlusion branch crossing down the
middle of the anterior wall of the left ventricle.
A successful MI model was confirmed by ST seg-
ment elevation in leads II and regional cyanosis of
the myocardial surface.
Assessment of ventricular arrhythmias
Ischemia-induced ventricular arrhythmias
were determined in accordance with the Lambeth
Conventions [11, 12]. Ventricular ectopic beat
(VEB) was defined as identifiable premature
QRS complexes (premature with respect to the
P wave). Ventricular tachycardia (VT) was defined
as the occurrence of four or more consecutive
VEBs at a rate faster than the resting sinus rate.
Ventricular fibrillation (VF) was defined as uni-
dentifiable and low voltage QRS complexes. Oth-
er patterns of VEBs such as bigeminy, couplet
(two consecutive VEBs) and salvos (three con-
secutive VEBs) were included in VEBs and not
analyzed separately. VF may be sustained or may
convert spontaneously to a normal sinus rhythm.
VF resulting in death was considered as irrevers-
ible (Fig. 1).
The severity of arrhythmias was quantified by
the following scoring system [11, 12]:
— 0: 0–50 VEBs with no other arrhythmias du-
ring the 30-min ischemia period,
— 1: only 50–500 VEBs,
— 2: more than 500 VEBs, or one episode of spon-
taneously reversible VT or VF,
— 3: 2–30 episodes of spontaneously reversible
VT and/or VF,
Figure 1. Representative examples of different ventri-
cular arrhythmias during the 30-min ischemia; VT —
ventricular tachycardia; VF — ventricular fibrillation.
Salvos
Bigeminy Couplet VT
Spontaneous VF Reversible VF
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— 4: more than 30 episodes of spontaneously re-
versible VT and/or VF,
— 5: irreversible VF.
Statistical analysis
All values were expressed as mean ± SD or
median (interquartile range) for continuous varia-
bles or the percentage of incidence of ventricular
arrhythmia. One-way ANOVA or Welch was used
for comparisons among groups and the Student-
Neuman-Keuls or Dunnett T3 was used for post-
hoc multiple comparisons. Paired samples t test was
used for comparisons of heart rate and MBP within
each group. Mann-Whitney U test was used for ar-
rhythmia score between two groups; when more
than two groups were compared, Kruskale-Wallis
H test was used. Incidences of ventricular arrhyth-
mias (i.e. VT and VF) were used for comparisons
by Fisher’s exact test. Statistical significance was
defined as p < 0.05.
Results
Hemodynamics
There were no significant differences in heart rate
and MBP among each group (p > 0.05 for all). Heart
rate and MBP after 30-min ligation were slightly low-
er than those before 30-min ligation, but no statistical
significances were found (p > 0.05 for all; Table 1).
Ventricular arrhythmias during ischemia
In this MI model, severe ventricular arrhyth-
mias peaked at 5–25 min after coronary artery liga-
tion. Figure 1 shows different ventricular arrhyth-
mias during the 30-min ischemia.
Incidences of VT and VF
The incidence of VF (1/10, 10.0%) in MI-Ex-4
group was significantly decreased compared to that
in MI group (7/10, 70.0%; p < 0.05); however, there
was no significant difference in VT incidence (9/10,
90.0% vs. 10/10, 100% in MI group; p > 0.05). Ad-
ministration of 5-HD could abolish the protective
effect of Ex-4 on VF (6/10, 60.0%; p < 0.05). 5-HD
alone did not affect the incidences of VT and VF
during acute MI compared to those in MI group,
respectively (p > 0.05 for all; Fig. 2).
Durations of VT + VF
The duration of VT + VF in MI-Ex-4 group
(24.8 ± 10.5 s) was significantly shorter than that
in MI group (78.4 ± 21.9 s; p < 0.05). Administra-
tion of 5-HD abolished the effects of Ex-4 on dura-
tion of VT + VF (71.3 ± 19.7 s) compared to that
in MI-Ex-4 group (p < 0.05). 5-HD alone did not
affect the duration of VT + VF during acute
MI compared to that in MI group, respectively
(p > 0.05; Fig. 3).
Table 1. Heart rate and MBP before and after 30-min ischemia.
Group N Heart rate [bmp] MBP [mm Hg]
Before ligation After ligation Before ligation After ligation
MI 10 395 ± 16 390 ± 15 98 ± 7 92 ± 9
MI-Ex-4 10 396 ± 17 390 ± 14 97 ± 6 90 ± 11
MI-Ex-4-5-HD 10 397 ± 14 392 ± 20 95 ± 9 90 ± 13
MI-5-HD 10 398 ± 18 390 ± 21 97 ± 10 92 ± 11
Data were expressed as mean ± SD. There were no significant differences in heart rate and MBP among each group. Heart rate and MBP after 30-min
ligation were lower than those before 30-min ligation, but no statistical significance were found (all p > 0.05); MI — myocardial ischemia;
Ex-4 — exendin-4; 5-HD — 5-hydroxydecanoic acid; MBP — mean arterial blood pressure
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Figure 2. The incidences of VT and VF in MI, MI-Ex-4,
MI-Ex-4-5-HD and MI-5-HD group (n = 10 for each group);
#p < 0.05 vs. MI group; ^p < 0.05 vs. MI-Ex-4 group;
abbreviations as in Table 1 and Figure 1.
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Number of episodes of VF + VT and VEBs/min
The number of episodes of VT + VF and VEBs/
/min in MI-Ex-4 group (19.8 ± 9.8 and 2.2 ± 0.9)
were significantly decreased compared to those in
MI group (45.5 ± 11.3 and 6.9 ± 1.9; p < 0.05). Ad-
ministration of 5-HD could abolish the protective
effects of Ex-4 on the number of episodes of VT +
+ VF (41.4 ± 7.9) and VEBs/min (7.0 ± 2.1) compared
to those in MI-Ex-4 group (p < 0.05 for both). 5-HD
alone did not affect the number of episodes of VT +
+ VF and VEBs/min during acute MI compared to those
in MI group, respectively (p > 0.05 for both; Fig. 3).
Severity of arrhythmias
The severity of ventricular arrhythmias was
significantly attenuated by Ex-4 (3.00 [median],
2.25–3.00 [interquartile range]) compared to that in
MI group (4.00, 4.00–4.00) (p < 0.05). Administration
of 5-HD (4.00, 4.00–4.00) abolished the anti-arrhyth-
mic effect of Ex-4 on the severity of ventricular ar-
rhythmias compared to that in MI-Ex-4 (p < 0.05).
5-HD alone did not affect the severity of ventricu-
lar arrhythmias during acute MI compared to that in
MI group, respectively (both p > 0.05; Fig. 4).
Discussion
In this study, we found that Ex-4 could attenu-
ate ischemia-induced ventricular arrhythmias in rats.
Meanwhile, 5-HD, a specific inhibitor of mitochon-
drial KATP channels could abolish the anti-arrhythmic
effect of Ex-4. Thus, we speculated that Ex-4 could
attenuate ischemia-induced ventricular arrhythmias
by mediating mitochondrial KATP channels.
Previous studies showed that GLP-1 and GLP-1
receptor agonists could reduce MI-reperfusion in-
jury and improve cardiac function [2–5, 14]. Recent-
ly, Chinda et al. [6] firstly showed that dipeptidyl
peptidase-4 inhibitor, a drug for postponing the
degradation of GLP-1 and could promote GLP-1 to
exert more longer protective effect during MI, could
attenuated the shortening of the effective refracto-
ry period, decreased the number of ventricular pre-
mature beats, increased the VF threshold, suggest-
ing that GLP-1 could decrease ischemia-induced
ventricular arrhythmias. In the present study, we
found that Ex-4, a GLP-1 receptor agonist, could
also attenuate the genesis of ventricular arrhyth-
mias during MI without affecting hemodynamics.
Yamamoto et al. [15] showed that GLP-1 receptor
stimulation including Ex-4 could increase blood
pressure and heart rate in a dose dependent, how-
ever, these affection only last little time and could
return to basal levels within 40–50 min. In this
study, we inject Ex-4 1 h before ischemia, thus, Ex-4
did not affect the hemodynamics during MI period.
These further indicated that GLP-1 and its receptor
agonists may provide an anti-arrhythmic effect
during MI.
Mitochondrial KATP channels was involved in
the anti-arrhythmic effect of ischemic precondition-
ing or pharmacological preconditioning during MI
[7–9]. In this study, we found that 5-HD, a specific
inhibitor of mitochondrial KATP channels could abo-
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Figure 4. Distribution of the arrhythmia score during
30-min ischemia in MI, MI-Ex-4, MI-Ex-4-5-HD and MI-
-5-HD group (n = 10 for each group); #p < 0.05 vs. MI
group; ^p < 0.05 vs. MI-Ex-4 group; abbreviations as
in Table 1 and Figure 1.
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Figure 3. Durations of episodes of VF + VT and VEBs/
/min during 30-min ischemia in MI, MI-Ex-4, MI-Ex-4-5-
-HD and MI-5-HD group (n = 10 for each group); #p <
< 0.05 vs. MI group; ^p < 0.05 vs. MI-Ex-4 group;
VEBs — ventricular ectopic beats; other abbreviations
as in Table 1 and Figure 1.
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lish the anti-arrhythmic effect of Ex-4, indicating that
mitochondrial KATP channels may be involved in the
anti-arrhythmic effect of Ex-4. Many studies
showed that activation of mitochondrial KATP chan-
nels could limit mitochondrial Ca2+ overload and
maintain mitochondrial Ca2+ homeostasis during MI
[16, 17]; mitochondrial Ca2+ homeostasis plays a fun-
damental role in cytosolic free Ca2+ homeostasis and
could prevent ischemia-induced cytosolic free Ca2+
overload [18, 19] which plays an important role in
ischemia-induced ventricular arrhythmias [20].
Thus, mitochondrial KATP channels was involved in
the anti-arrhythmic effect of Ex-4 during MI.
Limitations of the study
In the study, we only investigated the effect of
Ex-4 on ischemia-induced ventricular arrhythmias
and observed that the specific inhibitor of mitochon-
drial KATP channels could abolish the anti-arrhythmic
effect of Ex-4. The precise mechanisms underlying
our observation and their clinical relevance will re-
quire future elucidation. We need to investigate the
effect of Ex-4 the change of intracellular Ca2+ con-
centration or Ca2+ channels in the future study.
Conclusions
The present study suggested that Ex-4 could
attenuate ischemia-induced ventricular arrhythmias
in rats which may be through mediating mitochon-
drial KATP channels.
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